3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
6
Phase 2
5
Phase 1/2
2
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
276
Gastrointestinal
10
Gynecologic
9
Genitourinary
9
Thoracic
4
Head & Neck
4
Dermatologic
3
Classical hematology
3
CNS
3
Sarcoma
2
Plasma cell
2
Other
2
Lymphoid
2
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
15
Neoplasms
3
Gastro-enteropancreatic neuroendocrine tumor
3
Prostatic Neoplasms
2
Carcinoid Tumor
2
Serotonin Syndrome
1
Pituitary Neoplasms
1
Pituitary ACTH Hypersecretion
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Hypoglycemia
1
Dumping Syndrome
1
Disease
1
Digestive System Neuroendocrine Tumor G1
1
Colorectal Neoplasms
1
Carcinoma, Large Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Adenoma
1
Acromegaly
1
Interventions
gadoteridol
1
gadoterate meglumine
1
gadolinium ethoxybenzyl DTPA
1
gadodiamide
1
gadobutrol
1
gadobenic acid
1
Neuropsychological Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Breast Neoplasms
×
NET
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled